Pharmasset Sets Inhibitex-to-Achillion Drugmaker Deals

Pharmasset Sets Inhibitex-to-Achillion Drugmaker Deals

David Paul Morris/Bloomberg

Gilead, the world’s largest maker of HIV medicines, is paying $137 a share in cash for Pharmasset to gain an oral drug in development for a virus that is now largely treated with injections.